Medicare Enrolled
Dr. Madaiah Revana, MD PA
Interventional Cardiology · Humble, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Revana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Revana?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Revana
Dr. Madaiah Revana is an interventional cardiology specialist in Humble, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Revana performed 5,024 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Revana received a total of $135,321 from 58 pharmaceutical and/or device companies across 999 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Revana is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 15% volume in TX
$135,321 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,024
Medicare services
Top 15% in TX for interventional cardiology
Not available
Unique patients (not deduplicated)
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
677 | $94 | $150 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
668 | $31 | $65 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
561 | $10 | $21 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
457 | $38 | $79 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
432 | $64 | $96 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
403 | $37 | $95 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
226 | $20 | $32 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
217 | $146 | $268 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
141 | $146 | $237 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
136 | $50 | $94 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
135 | $36 | $48 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
131 | $351 | $2,100 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
98 | $23 | $33 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
70 | $92 | $143 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
65 | $1,319 | $2,318 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
57 | $188 | $319 |
| Ultrasound-guided injection into a single leg vein A chemical agent is injected into one incompetent vein in the leg while using ultrasound to guide the needle placement. |
49 | $1,066 | $1,607 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
48 | $112 | $175 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
43 | $183 | $1,000 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
43 | $40 | $59 |
| Injection, dipyridamole, per 10 mg | 42 | $3 | $75 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
41 | $149 | $235 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
41 | $57 | $95 |
| Telephone medical discussion, 5-10 minutes A brief phone conversation with a healthcare provider lasting between 5 and 10 minutes. |
40 | $9 | $14 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
37 | $19 | $25 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
24 | $10 | $55 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
22 | $30 | $83 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
20 | $35 | $225 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
18 | $11 | $19 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
17 | $668 | $1,025 |
| Continuous external EKG monitoring, 1 week Recording, analysis, and interpretation of a continuous external electrocardiogram performed over a period of more than one week. |
17 | $213 | $1,000 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
16 | $22 | $30 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
16 | $21 | $75 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $31 | $49 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.1% high complexity
18.0% medium
74.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$135,321
Total received (2018-2024)
Avg $19,332/year across 7 years
Top 5% in TX for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
999
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,508
2023
$6,049
2022
$10,821
2021
$12,942
2020
$11,546
2019
$41,338
2018
$46,118
Payments by company (2024)
Janssen Pharmaceuticals, Inc
$3,576
Medtronic, Inc.
$968
Boston Scientific Corporation
$497
Lexicon Pharmaceuticals, Inc.
$195
Abbott Laboratories
$159
Recor Medical Inc
$149
Merck Sharp & Dohme LLC
$126
Novo Nordisk Inc
$96
Bayer Healthcare Pharmaceuticals Inc.
$95
AstraZeneca Pharmaceuticals LP
$78
Azurity Pharmaceuticals, Inc.
$66
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$63
AngioDynamics, Inc.
$50
Kestra Medical Technology Services, Inc.
$49
ABIOMED
$46
SANOFI-AVENTIS U.S. LLC
$43
Esperion Therapeutics, Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Impulse Dynamics (USA) Inc.
$34
Novartis Pharmaceuticals Corporation
$33
Tactile Systems Technology Inc
$33
Actelion Pharmaceuticals US, Inc.
$22
Bard Peripheral Vascular, Inc.
$19
Amgen Inc.
$17
PFIZER INC.
$14
Top 3 companies account for 77.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$74,077
Amarin Pharma Inc.
$18,842
Novartis Pharmaceuticals Corporation
$7,369
Abbott Laboratories
$7,335
BIOTRONIK INC.
$5,246
Medtronic, Inc.
$4,039
Medtronic Vascular, Inc.
$2,579
BOSTON SCIENTIFIC CORPORATION
$2,424
Bard Peripheral Vascular, Inc.
$2,093
Venclose Inc.
$1,722
Boston Scientific Corporation
$1,532
Impulse Dynamics (USA) Inc.
$754
SANOFI-AVENTIS U.S. LLC
$581
Boehringer Ingelheim Pharmaceuticals, Inc.
$460
Esperion Therapeutics, Inc.
$427
Lexicon Pharmaceuticals, Inc.
$385
Beckman Coulter, Inc.
$350
Merck Sharp & Dohme LLC
$348
Novo Nordisk Inc
$342
Amgen Inc.
$337
Actelion Pharmaceuticals US, Inc.
$333
HeartFlow, Inc.
$307
Tactile Systems Technology Inc
$287
Philips Electronics North America Corporation
$281
AstraZeneca Pharmaceuticals LP
$280
E.R. Squibb & Sons, L.L.C.
$212
Bayer HealthCare Pharmaceuticals Inc.
$200
Recor Medical Inc
$149
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$148
Biocompatibles, Inc.
$144
Azurity Pharmaceuticals, Inc.
$133
PFIZER INC.
$129
Relypsa, Inc.
$128
Avinger Inc.
$125
Arineta, Inc
$124
ARALEZ PHARMACEUTICALS US INC.
$107
Gilead Sciences, Inc.
$105
Janssen Scientific Affairs, LLC
$102
Regeneron Healthcare Solutions, Inc.
$99
ARBOR PHARMACEUTICALS, INC.
$99
Bayer Healthcare Pharmaceuticals Inc.
$95
BARD PERIPHERAL VASCULAR, INC.
$58
AngioDynamics, Inc.
$50
Kestra Medical Technology Services, Inc.
$49
Vifor Pharma, Inc.
$47
ABIOMED
$46
Aziyo Biologics, Inc.
$36
Merck Sharp & Dohme Corporation
$31
Alnylam Pharmaceuticals Inc.
$23
Edwards Lifesciences Corporation
$23
Cardiovascular Systems Inc.
$23
GlaxoSmithKline, LLC.
$20
Arbor Pharmaceuticals, Inc.
$17
NormaTec Industries, LP
$16
Coala Life Inc
$15
Cook Medical LLC
$14
SCPHARMACEUTICALS INC.
$13
Althera Pharmaceuticals LLC
$12
Top 3 companies account for 74.1% of all-time payments
Associated products mentioned in payments ›
ANORO ELLIPTA · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Accent Pacemaker · Acticor · Assure WCD · BIOMONITOR · BRILINTA · CHANTIX · CLOSUREFAST · CONFIRM RX · COOK CELECT · COREVALVE EVOLUT R · CRT Leads · CRT-Ds · CardioGraphe · ClosureFast · Coala Heart Monitor · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · DXI 800 · ECM Patch · EDARBI · ELIQUIS · ENTRESTO · EVRSF · Edarbi · Edarbyclor · Endurant · Ensite Cardiac Mapping System · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · Flexitouch Plus · GENERAL ANGIOPLASTY · GENERAL ATHERECTOMY · General - Vascular Access · HORIZANT · HeartMate 3 Left Ventricular Dev · IGT D Peripheral · IGT_D Peripheral · IN.PACT Admiral · Impella · Inpefa · JANUVIA · JARDIANCE · JOT DX · Kerendia · LEQVIO · LifeVest · MULTAQ · Merlin Connectivity and Remote · MitraClip System · NEXLETOL · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PANTHERIS · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Peripheral Orbital Atherectomy System · Pouch · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · REVEAL LINQ · Renamic Neo · Repatha · Reveal LINQ · Roszet · Rybelsus · Solia · TurboHawk · UPTRAVI · VARITHENA · VENASEAL · VENOVO · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Veltassa · VenaSeal · Venclose · Venclose Maven Catheter · Verquvo · Via · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZONTIVITY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Interventional cardiologists in nearby ZIP areas
55
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN NORTHEAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Revana is a clinical cardiology specialist, with above-average Medicare volume (top 15% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Revana experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Revana performed 677 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Revana receive payments from pharmaceutical companies?
Yes. Dr. Revana received a total of $135,321 from 58 companies across 999 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Revana's costs compare to other interventional cardiologists in Humble?
Dr. Revana's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Revana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Humble
Browse interventional cardiologists in Humble ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in TX
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in TX
Which TX interventional cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology